DGX:NYE-Quest Diagnostics Incorporated (USD)

EQUITY | Diagnostics & Research | New York Stock Exchange

Last Closing

USD 135.42

Change

-2.13 (-1.55)%

Market Cap

USD 11.95B

Volume

1.02M

Analyst Target

USD 138.69
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Quest Diagnostics Inc is the provider of diagnostic testing, information and services, providing insights that enable patients and physicians to make healthcare decisions.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-04-25 )

Largest Industry Peers for Diagnostics & Research

Symbol Name Price(Change) Market Cap
TMO Thermo Fisher Scientific Inc

N/A

USD 220.96B
DHR Danaher Corporation

N/A

USD 182.08B
IQV IQVIA Holdings Inc

N/A

USD 42.75B
A Agilent Technologies Inc

N/A

USD 40.87B
MTD Mettler-Toledo International I..

N/A

USD 27.82B
WAT Waters Corporation

N/A

USD 19.89B
LH Laboratory Corporation of Amer..

N/A

USD 17.77B
CRL Charles River Laboratories

N/A

USD 13.04B
RVTY Revvity Inc.

N/A

USD 12.54B
QGEN Qiagen NV

N/A

USD 9.22B

ETFs Containing DGX

OWLU:LSE 2.44 % 0.00 %

N/A

N/A
RSPH Invesco S&P 500® Equal.. 1.62 % 0.00 %

N/A

USD 1.02B
DSMC ETF Series Solutions 1.38 % 0.00 %

N/A

USD 0.06B
RYH 0.00 % 0.40 %

N/A

N/A
XHS SPDR® S&P Health Care Se.. 0.00 % 0.35 %

N/A

USD 0.08B
GERM ETFMG Treatments Testing .. 0.00 % 0.00 %

N/A

USD 0.01B

Market Performance

  Market Performance vs. Industry/Classification (Diagnostics & Research) Market Performance vs. Exchange (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -1.78% 60% D- 37% F
Dividend Return 1.06% 86% B+ 51% F
Total Return -0.73% 60% D- 36% F
Trailing 12 Months  
Capital Gain -3.96% 54% F 28% F
Dividend Return 2.04% 83% B 30% F
Total Return -1.92% 54% F 23% F
Trailing 5 Years  
Capital Gain 42.04% 42% F 71% C-
Dividend Return 13.15% 100% F 52% F
Total Return 55.19% 50% F 71% C-
Average Annual (5 Year Horizon)  
Capital Gain 7.59% 33% F 65% D
Dividend Return 9.57% 33% F 64% D
Total Return 1.98% 100% F 46% F
Risk Return Profile  
Volatility (Standard Deviation) 16.12% 100% F 66% D+
Risk Adjusted Return 59.37% 92% A 84% B
Market Capitalization 11.95B 50% F 87% B+

Key Financial Ratios

  Ratio vs. Industry/Classification (Diagnostics & Research) Ratio vs. Market (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 18.60 100% 50%
Price/Book Ratio 2.26 71% 38%
Price / Cash Flow Ratio 11.22 79% 33%
Price/Free Cash Flow Ratio 11.02 79% 38%
Management Effectiveness  
Return on Equity 14.62% 71% 71%
Return on Invested Capital 14.37% 80% 77%
Return on Assets 6.21% 79% 79%
Debt to Equity Ratio 69.92% 31% 48%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior capital utilization

The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.

Underpriced on cashflow basis

The stock is trading low compared to its peers on a price to cash flow basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Underpriced compared to earnings

The stock is trading low compared to its peers on a price to earning basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Underpriced on free cash flow basis

The stock is trading low compared to its peers on a price to free cash flow basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

What to not like:
Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector